Monday, October 20, 2025

Cannabis-Focused Investment Firm Silver Spike Looks To Raise US$85.0 Million On Its Nasdaq IPO

Management investment firm Silver Spike Investment Corp. (Nasdaq: SSIC) announced on Friday the pricing of its initial public offering on the Nasdaq Stock Market. The company went public on the US-based big board on February 4, 2022 under the ticker symbol “SSIC”.

The offering consists of 6,071,429 common shares at US$14.00 per share for potential total aggregate proceeds of US$85.0 million. The company also gave the underwriters the option to purchase additional 910,714 common shares at the same share price.

Stifel and Piper Sandler are managing the proposed offering as lead underwriters. 

The initial public offering is expected to close on February 9, 2022, subject to customary closing conditions. Net proceeds are expected to be used for its investment objective and strategies, which include debt and investments in the middle-market cannabis companies, and for general corporate purposes.

The newly-organized firm is being managed by health & wellness investment firm Silver Spike Capital.


Information for this briefing was found via Edagr and the companies mentioned. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

When 4% of Global Copper Disappears Overnight | David Gower – Emerita Resources

Mining M&A: Gold X2 Acquires Kesselrun Resources

They Said Oil Was Dead. They Were Wrong. | Michael Judson – Record Resources

Recommended

Military Seizes Power in Madagascar After President Flees

Altamira Gold Hits 395.5 Metres Of 0.4 g/t Gold At Maria Bonita

Related News

Mining Firm Austin Gold Prices US$13 Million IPO

Gold exploration company Austin Gold Corp. (NYSE: AUST) began trading on the New York Stock...

Wednesday, May 4, 2022, 02:20:00 PM

Biotech Firm AN2 Therapeutics Prices US$69 Million IPO

Biopharmaceutical company AN2 Therapeutics, Inc. (Nasdaq: ANTX) began trading on the Nasdaq Global Select Market...

Friday, March 25, 2022, 02:22:00 PM

Farmers Edge Sees Exercise Of Over-Allotment Option, Bringing IPO Proceeds To $143.8 Million

Farmers Edge (TSX: FDGE) has seen further capital inflows in connection with its initial public...

Tuesday, March 9, 2021, 08:55:06 AM

Biotech Firm CinCor Pharma Kicks Off Nasdaq IPO Roadshow

Clinical-stage biopharmaceutical company CinCor Pharma, Inc. is setting its sights on trading at the Nasdaq...

Tuesday, January 4, 2022, 02:36:00 PM

Fintech SPAC SHUAA Partners Acquisition I Prices US$100 Million IPO

Special purpose acquisition company SHUAA Partners Acquisition Corp I (Nasdaq: SHUAU) started trading its securities...

Thursday, March 3, 2022, 02:27:00 PM